Anatomic & Clinical Pathology in Stockton, CA
9 verified anatomic & clinical pathology doctors in Stockton.
Pathologists diagnose disease by examining tissue, blood, and other lab specimens.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Hong Li, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Lawrence, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. David Jensen, MD
Anatomic & Clinical Pathology
CMS Open Payments· $226.56 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$226.56
Total received
10
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to David Jensen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mark Nishiki, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Thomas Yu, MD
Anatomic & Clinical Pathology
CMS Open Payments· $24.57 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$24.57
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Thomas Yu do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lily Pang, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Beiru Chen, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jeffrey Mcdavit, MD
Anatomic & Clinical Pathology
CMS Open Payments· $13.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$13.18
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Jeffrey Mcdavit do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Andrew Fong, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.